Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medicare reimbursement tables, patient-day metrics, and hospice turnover data are scattered across hundreds of pages of Enhabit’s disclosures. If parsing those figures in the latest Enhabit annual report 10-K simplified seems daunting, you’re not alone. Healthcare accounting rules create footnotes that read like another language. Stock Titan’s AI turns that language into clear insights, making Enhabit SEC filings explained simply. Whether you’re scanning for regulatory risks or auditing segment margins, our platform surfaces what matters before you wade through dense jargon.
Need the next Enhabit quarterly earnings report 10-Q filing or an alert on Enhabit Form 4 insider transactions real-time? Our engine pulls every document the moment it hits EDGAR and delivers AI-powered summaries in seconds. Investors searching for:
- Enhabit insider trading Form 4 transactions
- Enhabit proxy statement executive compensation
- Enhabit 8-K material events explained
- Enhabit earnings report filing analysis
receive a single dashboard that connects each form to real questions: What did executives buy, how did home-health margins shift, and did CMS rule changes impact revenue guidance?
Understanding Enhabit SEC documents with AI also means context. Our tools highlight hospice census trends, regional payor mixes, and quality-of-care metrics buried deep in footnotes. Curious about Enhabit executive stock transactions Form 4 ahead of a rate update? Want a red-lined comparison that shows how the new filing differs from last year? Stock Titan provides real-time updates, side-by-side comparisons, and plain-English explanations, so you can decide faster, act sooner, and focus on the fundamentals driving home-health performance.
Enhabit (EHAB) reported a return to profitability in Q3 2025. Net service revenue was $263.6M, up 3.9% year over year. Operating income reached $16.8M versus a loss in the prior year, and net income attributable to Enhabit was $11.1M, or $0.22 per diluted share, compared with a loss of $110.2M a year ago, which included a goodwill impairment.
Hospice drove the quarter with revenue of $63.1M, up 20.0%, while Home Health was $200.5M, down 0.2%. Adjusted EBITDA was $27.0M versus $24.5M. For the first nine months, revenue was $789.6M (up 1.7%) and net income was $34.1M, helped by a $19.3M gain on sale of an investment. Interest expense fell with lower borrowings and rates.
Cash rose to $56.9M, and total debt was $463.8M, including $333.5M on the term loan and $125.0M drawn on the revolver. The company closed or consolidated 13 branches year‑to‑date and remained in compliance with credit facility covenants. CMS finalized a 2.6% hospice payment increase effective October 1, 2025, and proposed a 6.4% home health decrease for 2026.
Enhabit, Inc. furnished an 8-K announcing it issued a press release reporting financial results for the quarter ended September 30, 2025. The company also provided supplemental materials for its earnings discussion.
Exhibit 99.1 contains the earnings press release dated November 5, 2025, and Exhibit 99.2 includes supplemental information for the third quarter 2025 earnings call. The call is scheduled for 9:00 a.m. Eastern Time on Thursday, November 6, 2025. The materials under Items 2.02 and 7.01 are being furnished, not filed.
Enhabit, Inc. (EHAB) director Erin Hoeflinger purchased 2,969 shares of the company's common stock on
Enhabit, Inc. (EHAB) filed a Form 4 reporting a director’s share acquisition. On 10/10/2025, the reporting person acquired 2,969 shares of common stock at a price of $8 per share. Following this transaction, the filer beneficially owns 67,850 shares. Ownership is reported as direct.
Stuart M. McGuigan, a director of Enhabit, Inc. (EHAB), reported a purchase of 2,344 shares of the company's common stock on
Enhabit, Inc. (EHAB) director Gregory S. Rush acquired
Insider purchase reported: A director of Enhabit, Inc. (EHAB) acquired 2,344 shares of common stock on
Director Mark W. Ohlendorf reported a non-derivative purchase of 2,344 shares of Enhabit, Inc. (EHAB) on 10/10/2025 at a reported price of
Insider purchase reported: A Form 4 shows director Charles M. Elson acquired 2,344 shares of Enhabit, Inc. (EHAB) on
Insider purchase recorded on Form 4. A director, Jeffrey Bolton, purchased 4,688 shares of Enhabit, Inc. at
FAQ
What is the current stock price of Enhabit (EHAB)?
What is the market cap of Enhabit (EHAB)?
